Related references
Note: Only part of the references are listed.Understanding the mechanisms and treatment options in cancer cachexia
Kenneth Fearon et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
TWEAK and TRAF6 regulate skeletal muscle atrophy
Ashok Kumar et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2012)
Follistatin-mediated skeletal muscle hypertrophy is regulated by Smad3 and mTOR independently of myostatin
Catherine E. Winbanks et al.
JOURNAL OF CELL BIOLOGY (2012)
Targeting the TGFβ signalling pathway in disease
Rosemary J. Akhurst et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Molecular Mechanisms and Treatment Options for Muscle Wasting Diseases
Markus A. Rueegg et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 51, 2011 (2011)
Dimethylarginine Dimethylaminohydrolase-1 Is the Critical Enzyme for Degrading the Cardiovascular Risk Factor Asymmetrical Dimethylarginine
Xinli Hu et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Generation of a Specific Activin Antagonist by Modification of the Activin A Propeptide
Yogeshwar Makanji et al.
ENDOCRINOLOGY (2011)
Prodomains regulate the synthesis, extracellular localisation and activity of TGF-β superfamily ligands
Craig A. Harrison et al.
GROWTH FACTORS (2011)
TGF-β Regulates miR-206 and miR-29 to Control Myogenic Differentiation through Regulation of HDAC4
Catherine E. Winbanks et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Gene expression profiling of skeletal muscles treated with a soluble activin type IIB receptor
Fedik Rahimov et al.
PHYSIOLOGICAL GENOMICS (2011)
Treating cancer cachexia to treat cancer
Se-Jin Lee et al.
SKELETAL MUSCLE (2011)
Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival
Xiaolan Zhou et al.
CELL (2010)
Interleukin 6 as a Key Regulator of Muscle Mass during Cachexia
James A. Carson et al.
EXERCISE AND SPORT SCIENCES REVIEWS (2010)
The TWEAK-Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice
Ashwani Mittal et al.
JOURNAL OF CELL BIOLOGY (2010)
Regulation of the Intracellular Localization of Foxo3a by Stress-Activated Protein Kinase Signaling Pathways in Skeletal Muscle Cells
Stephan Clavel et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
PH Domain-Only Protein PHLDA3 Is a p53-Regulated Repressor of Akt
Tatsuya Kawase et al.
CELL (2009)
A new 'total' activin B enzyme-linked immunosorbent assay (ELISA): development and validation for human samples
Helen Ludlow et al.
CLINICAL ENDOCRINOLOGY (2009)
A Common Biosynthetic Pathway Governs the Dimerization and Secretion of Inhibin and Related Transforming Growth Factor β (TGFβ) Ligands
Kelly L. Walton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Translation Elongation Factor eEF1A Binds to a Novel Myosin Binding Protein-C-Like Protein
Francisco Mansilla et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
NO production results in suspension-induced muscle atrophy through dislocation of neuronal NOS
Naoki Suzuki et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Prevention of cachexia-like syndrome development and reduction of tumor progression in inhibin-deficient mice following administration of a chimeric activin receptor type II-murine Fc protein
Qinglei Li et al.
MOLECULAR HUMAN REPRODUCTION (2007)
Dual specificity phosphotase 18, interacting with SAPK, dephosphorylates SAPK and inhibits SAPK/JNK signal pathway in vivo
Qihan Wu et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2006)
Systemic administration of IGF-I enhances oxidative status and reduces contraction-induced injury in skeletal muscles of mdx dystrophic mice
Jonathan D. Schertzer et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
Activin A circulating levels in patients with bone metastasis from breast or prostate cancer
Gaetano Leto et al.
CLINICAL & EXPERIMENTAL METASTASIS (2006)
Cancer cachexia is regulated by selective targeting of skeletal muscle gene products
S Acharyya et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex
J Brugarolas et al.
GENES & DEVELOPMENT (2004)
Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6
MJ Blankinship et al.
MOLECULAR THERAPY (2004)
Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases
NM Wolfman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Myostatin negatively regulates satellite cell activation and self-renewal
S McCroskery et al.
JOURNAL OF CELL BIOLOGY (2003)
Activins, inhibins, and follistatins: From endocrinology to signaling. A paradigm for the new millennium
C Welt et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2002)
Induction of cachexia in mice by systemically administered myostatin
TA Zimmers et al.
SCIENCE (2002)
Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo
SC Bodine et al.
NATURE CELL BIOLOGY (2001)
The kyphoscoliosis (ky) mouse is deficient in hypertrophic responses and is caused by a mutation in a novel muscle-specific protein
G Blanco et al.
HUMAN MOLECULAR GENETICS (2001)
Transcriptional control by the TGF-β/Smad signaling system
J Massagué et al.
EMBO JOURNAL (2000)
Betaglycan binds inhibin and can mediate functional antagonism of activin signalling
KA Lewis et al.
NATURE (2000)
Share Paper
